(S)-5-Hydroxy-hept-6-ynoic acid | 1070971-84-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (S)-5-Hydroxy-hept-6-ynoic acid
• 英文别名: (5S)-5-hydroxyhept-6-ynoic acid
• CAS: 1070971-84-4
• 化学式: C₇H₁₀O₃
• 分子量: 142.155
• InChiKey: RWQMJHDIHSBEHT-ZCFIWIBFSA-N

物化性质

• 沸点：
  295.4±30.0 °C(Predicted)
• 密度：
  1.181±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (S)-5-Hydroxy-hept-6-ynoic acid 在 copper(l) iodide 、 四(三苯基膦)钯 、 potassium carbonate 、 正丁胺 、 锌 作用下， 以 甲醇 、 水 、 苯 为溶剂， 反应 18.0h， 生成 白三烯B4
  参考文献：
  名称：

  Stereocontrolled total synthesis of leukotriene B4

  摘要：

  A stereocontrolled synthesis of leukotriene B4 (1) is accomplished by assembly of the chiral synthons 2 and 4, prepared from D-mannitol and 2-deoxy-D-ribose, with (E)-dichloroethylene.

  DOI：

  10.1021/jo00028a046
• 作为产物：
  描述：

  Methyl (5S)-7-Bromo-5-hydroxyhept-6-enoate 在 potassium tert-butylate 作用下， 以 乙二醇二甲醚 为溶剂， 生成 (S)-5-Hydroxy-hept-6-ynoic acid
  参考文献：
  名称：

  Stereocontrolled total synthesis of leukotriene B4

  摘要：

  A stereocontrolled synthesis of leukotriene B4 (1) is accomplished by assembly of the chiral synthons 2 and 4, prepared from D-mannitol and 2-deoxy-D-ribose, with (E)-dichloroethylene.

  DOI：

  10.1021/jo00028a046

文献信息

• Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP1149834A1

  公开（公告）日：2001-10-31

  Diaminopyrimidines of general formula I wherein R1signifies hydrogen, R2signifies C3-5-ω-carboxyalkyl; R3signifies C1-5-alkyl; and their pharmaceutically acceptable acid addition salts have antibiotic properties and can be used in the control or prevention of infectious diseases.

  通式 I 的二氨基嘧啶 其中 R1 表示氢 R2表示 C3-5-ω-羧基烷基 R3表示C1-5-烷基； 及其药学上可接受的酸加成盐具有抗生素特性，可用于控制或预防传染病。
• DIAMINOPYRIMIDINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTIBACTERIAL
  申请人：Arpida AG,

  公开号：EP0866791B1

  公开（公告）日：2002-01-30
• Biochemical Markers for Disease States and Genes for Identification of Biochemical Defects
  申请人：Spur Bernd

  公开号：US20110229883A1

  公开（公告）日：2011-09-22

  The present invention relates to a system utilizing biochemical markers and genetic markers to diagnose, predict, and/or monitor intervention of a number of diseases and conditions that have unresolved oxidative stress as an important component. The present invention relates generally to markers and assays for diagnosing, predicting, and monitoring disease, particularly disease-relevant oxidative stress and lipid metabolites and mediators. The oxidative stress, lipid metabolite and lipid mediator biochemical and genetic markers may be further combined with other disease associated or disease relevant markers in methods and assays for diagnosis, monitoring, and assessment of disease, particularly of complex diseases with multi-component factors. The system, methods and assays are applicable to various diseases, including autism, asthma, and Alzheimer's disease.
• US5773446A
  申请人：——

  公开号：US5773446A

  公开（公告）日：1998-06-30
• [EN] BIOCHEMICAL MARKERS FOR DISEASE STATES AND GENES FOR IDENTIFICATION OF BIOCHEMICAL DEFECTS<br/>[FR] MARQUEURS BIOCHIMIQUES POUR DES ÉTATS PATHOLOGIQUES ET GÈNES POUR L'IDENTIFICATION D'ANOMALIES BIOCHIMIQUES
  申请人：UNIV NEW JERSEY MED

  公开号：WO2008124187A1

  公开（公告）日：2008-10-16

  [EN] The present invention relates to a system utilizing biochemical markers and genetic markers to diagnose, predict, and/or monitor intervention of a number of diseases and conditions that have unresolved oxidative stress as an important component. The present invention relates generally to markers and assays for diagnosing, predicting, and monitoring disease, particularly disease-relevant oxidative stress and lipid metabolites and mediators. The oxidative stress, lipid metabolite and lipid mediator biochemical and genetic markers may be further combined with other disease associated or disease relevant markers in methods and assays for diagnosis, monitoring, and assessment of disease, particularly of complex diseases with multi-component factors. The system, methods and assays are applicable to various diseases, including autism, asthma, and Alzheimer's disease.
  [FR] La présente invention concerne un système utilisant des marqueurs biochimiques et des marqueurs génétiques pour diagnostiquer, prévoir et/ou surveiller la survenue d'un certain nombre de maladies et d'états qui comptent un stress oxydant non résolu comme composant important. La présente invention concerne généralement des marqueurs et des dosages destinés à diagnostiquer, prédire et surveiller des maladies, particulièrement un stress oxydant, des métabolites de lipides et des médiateurs liés à une maladie. Les marqueurs biochimiques et génétiques du stress oxydant, des métabolites de lipides et des médiateurs de lipides peuvent être en outre combinés à d'autres marqueurs associés à une maladie ou liés à une maladie dans des procédés et des dosages destinés au diagnostic, à la surveillance et à l'évaluation de maladies, particulièrement de maladies complexes avec des facteurs à plusieurs composantes. Le système, les procédés et les dosages peuvent s'appliquer à diverses maladies, dont l'autisme, l'asthme et la maladie d'Alzheimer.